rs3738423

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014625.4(NPHS2):​c.288C>T​(p.Ser96Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0842 in 1,612,474 control chromosomes in the GnomAD database, including 6,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 615 hom., cov: 32)
Exomes 𝑓: 0.084 ( 5692 hom. )

Consequence

NPHS2
NM_014625.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.42

Publications

20 publications found
Variant links:
Genes affected
NPHS2 (HGNC:13394): (NPHS2 stomatin family member, podocin) This gene encodes a protein that plays a role in the regulation of glomerular permeability. Mutations in this gene cause steroid-resistant nephrotic syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
NPHS2 Gene-Disease associations (from GenCC):
  • nephrotic syndrome, type 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, G2P
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 1-179564780-G-A is Benign according to our data. Variant chr1-179564780-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260426.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.42 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0857 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHS2NM_014625.4 linkc.288C>T p.Ser96Ser synonymous_variant Exon 2 of 8 ENST00000367615.9 NP_055440.1 Q9NP85-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHS2ENST00000367615.9 linkc.288C>T p.Ser96Ser synonymous_variant Exon 2 of 8 1 NM_014625.4 ENSP00000356587.4 Q9NP85-1
NPHS2ENST00000367616.4 linkc.288C>T p.Ser96Ser synonymous_variant Exon 2 of 7 1 ENSP00000356588.4 Q9NP85-2

Frequencies

GnomAD3 genomes
AF:
0.0841
AC:
12797
AN:
152076
Hom.:
615
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0882
Gnomad AMI
AF:
0.112
Gnomad AMR
AF:
0.0596
Gnomad ASJ
AF:
0.0747
Gnomad EAS
AF:
0.0889
Gnomad SAS
AF:
0.0139
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0852
Gnomad OTH
AF:
0.0784
GnomAD2 exomes
AF:
0.0734
AC:
18446
AN:
251188
AF XY:
0.0706
show subpopulations
Gnomad AFR exome
AF:
0.0896
Gnomad AMR exome
AF:
0.0355
Gnomad ASJ exome
AF:
0.0634
Gnomad EAS exome
AF:
0.0939
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.0851
Gnomad OTH exome
AF:
0.0760
GnomAD4 exome
AF:
0.0842
AC:
122921
AN:
1460280
Hom.:
5692
Cov.:
31
AF XY:
0.0815
AC XY:
59206
AN XY:
726504
show subpopulations
African (AFR)
AF:
0.0846
AC:
2830
AN:
33458
American (AMR)
AF:
0.0375
AC:
1678
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0644
AC:
1682
AN:
26126
East Asian (EAS)
AF:
0.0675
AC:
2679
AN:
39686
South Asian (SAS)
AF:
0.0138
AC:
1186
AN:
86240
European-Finnish (FIN)
AF:
0.131
AC:
6990
AN:
53408
Middle Eastern (MID)
AF:
0.0135
AC:
78
AN:
5764
European-Non Finnish (NFE)
AF:
0.0908
AC:
100818
AN:
1110562
Other (OTH)
AF:
0.0825
AC:
4980
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
5391
10782
16173
21564
26955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3772
7544
11316
15088
18860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0841
AC:
12803
AN:
152194
Hom.:
615
Cov.:
32
AF XY:
0.0832
AC XY:
6191
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0881
AC:
3657
AN:
41516
American (AMR)
AF:
0.0595
AC:
910
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0747
AC:
259
AN:
3468
East Asian (EAS)
AF:
0.0891
AC:
462
AN:
5186
South Asian (SAS)
AF:
0.0137
AC:
66
AN:
4820
European-Finnish (FIN)
AF:
0.131
AC:
1381
AN:
10576
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0852
AC:
5794
AN:
68014
Other (OTH)
AF:
0.0781
AC:
165
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
586
1172
1758
2344
2930
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0799
Hom.:
497
Bravo
AF:
0.0798
Asia WGS
AF:
0.0380
AC:
133
AN:
3478
EpiCase
AF:
0.0764
EpiControl
AF:
0.0756

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nephrotic syndrome, type 2 Benign:3
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 29, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Steroid-resistant nephrotic syndrome Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.3
DANN
Benign
0.22
PhyloP100
-2.4
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3738423; hg19: chr1-179533915; COSMIC: COSV62635462; API